137 related articles for article (PubMed ID: 38785304)
1. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.
Hara S; Tsuji T; Fukasawa Y; Hisano S; Morito S; Hyodo T; Goto S; Nishi S; Yoshimoto A; Itoh T
Virchows Arch; 2019 Jun; 474(6):735-743. PubMed ID: 30868298
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.
Taguchi S; Koshikawa Y; Ohyama S; Miyachi H; Ozawa H; Asada H
BMC Nephrol; 2019 Feb; 20(1):43. PubMed ID: 30727973
[TBL] [Abstract][Full Text] [Related]
4. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
5. Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy.
von Haxthausen F; Reinhard L; Pinnschmidt HO; Rink M; Soave A; Hoxha E; Stahl RAK
Front Immunol; 2018; 9():3035. PubMed ID: 30619370
[TBL] [Abstract][Full Text] [Related]
6. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.
Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527
[TBL] [Abstract][Full Text] [Related]
7. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
8. An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.
Hoxha E; Beck LH; Wiech T; Tomas NM; Probst C; Mindorf S; Meyer-Schwesinger C; Zahner G; Stahl PR; Schöpper R; Panzer U; Harendza S; Helmchen U; Salant DJ; Stahl RA
J Am Soc Nephrol; 2017 Feb; 28(2):520-531. PubMed ID: 27436855
[TBL] [Abstract][Full Text] [Related]
9. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
10. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
11. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.
Weinmann-Menke J; Holtz S; Sollinger D; Dörken M; Boedecker S; Schamberger B; Pfister F; Amann K; Lutz J
Am J Kidney Dis; 2019 Dec; 74(6):849-852. PubMed ID: 31451329
[TBL] [Abstract][Full Text] [Related]
13. Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study.
Hanset N; Aydin S; Demoulin N; Cosyns JP; Castanares-Zapatero D; Crott R; Cambier JF; Pochet JM; Gillerot G; Reginster F; Houssiau F; Debiec H; Ronco P; Jadoul M; Morelle J;
Am J Kidney Dis; 2020 Nov; 76(5):624-635. PubMed ID: 32668319
[TBL] [Abstract][Full Text] [Related]
14. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
15. Circulating antibodies against M-type phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in Chinese patients with membranous nephropathy.
Tian C; Li L; Liu T; Qu X; Qiu Y
Int Urol Nephrol; 2019 Aug; 51(8):1371-1377. PubMed ID: 31227982
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
Tomas NM; Hoxha E; Reinicke AT; Fester L; Helmchen U; Gerth J; Bachmann F; Budde K; Koch-Nolte F; Zahner G; Rune G; Lambeau G; Meyer-Schwesinger C; Stahl RA
J Clin Invest; 2016 Jul; 126(7):2519-32. PubMed ID: 27214550
[TBL] [Abstract][Full Text] [Related]
17. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
Matsumoto A; Matsui I; Mano K; Mizuno H; Katsuma Y; Yasuda S; Shimada K; Inoue K; Oki T; Hanai T; Kojima K; Kaneko T; Isaka Y
BMC Nephrol; 2021 Jul; 22(1):253. PubMed ID: 34229600
[TBL] [Abstract][Full Text] [Related]
18. Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study.
Sharma SG; Larsen CP
Mod Pathol; 2018 Apr; 31(4):616-622. PubMed ID: 29243738
[TBL] [Abstract][Full Text] [Related]
19. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
[TBL] [Abstract][Full Text] [Related]
20. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
